recent
articl
critic
care
bermejomartin
colleagu
describ
hypercytokinemia
earli
signatur
host
respons
sever
infect
pandem
variant
influenza
viru
infect
usual
selflimit
natur
patient
develop
sever
symptom
requir
hospit
host
immun
respons
may
play
import
role
poor
outcom
infect
human
host
immun
respons
infect
unknown
time
studi
contribut
diseas
pathogenesi
desper
need
improv
prevent
treatment
strategi
analyz
cytokin
chemokin
hemagglutin
inhibit
activ
bermejomartin
colleagu
assess
earli
host
innat
adapt
immun
respons
patient
mildli
sever
infect
infect
induc
typic
innat
respons
mild
sever
case
sever
infect
respiratori
involv
character
earli
secret
cytokin
thu
hospit
patient
tend
show
high
system
level
mediat
stimul
respons
base
find
studi
abl
highlight
similar
cytokin
respons
sever
infect
pathogenesi
asthma
autoimmun
diseas
respons
primarili
involv
host
immun
defens
intracellular
pathogen
activ
cellular
immun
respons
effect
erad
infecti
agent
virus
inde
cell
produc
cytokin
involv
monocytemacrophagemedi
inflammatori
respons
respons
exhaust
prolong
may
result
host
damag
moreov
author
report
respons
may
implic
pathogenesi
autoimmun
disord
chronic
inflammatori
diseas
bermejomartin
colleagu
found
particularli
elev
follow
sever
infect
three
cytokin
known
mediat
antivir
proinflammatori
respons
author
also
found
signific
invers
relationship
pressur
oxygen
arteri
blood
sever
infect
patient
interestingli
previou
studi
alreadi
report
high
level
specif
proinflammatori
cytokin
chemokin
sever
sar
coronaviru
respiratori
syncyti
viru
infect
cell
requir
host
defens
intracellular
pathogen
promot
inflamm
induc
variou
proinflammatori
cytokin
chemokin
recruit
neutrophil
enhanc
antibodi
product
activ
cell
cell
secret
therebi
induc
massiv
tissu
reaction
also
cell
secret
commun
cell
immun
system
howev
uncontrol
product
cytokin
induc
tissu
damag
infect
tissu
addit
cell
wellknown
role
clear
pathogen
infect
induc
tissu
inflamm
autoimmun
diseas
interestingli
key
role
receptor
immunopatholog
influenza
infect
mous
model
recent
report
taken
togeth
find
show
sever
pandem
infect
character
earli
elev
key
immun
proinflammatori
mediat
particip
inflammatori
respons
proinflammatori
respons
may
caus
sever
respiratori
symptom
caus
infect
howev
author
also
provid
altern
version
stori
cytokin
may
reflect
vigor
antivir
host
respons
necessari
viral
clearanc
articl
first
describ
associ
sever
influenza
infect
respons
human
research
correctli
bring
fact
better
understand
immun
respons
new
viru
could
contribut
design
effect
therapi
similarli
result
studi
reinforc
import
earli
treatment
antivir
patient
high
risk
factor
pregnanc
asthma
obes
among
other
avoid
trigger
unwant
inflammatori
phenomena
could
explain
appear
pneumonia
patient
result
work
also
support
studi
drug
modul
immun
respons
treatment
diseas
moreov
studi
genet
polymorph
relev
gene
involv
develop
immun
respons
sever
infect
patient
could
interest
sinc
polymorph
could
strongli
influenc
gene
express
studi
would
help
understand
harm
benefici
role
cytokin
play
evolut
mild
sever
infect
report
confirm
respons
distinct
hallmark
sever
respiratori
compromis
follow
infect
ifn
interferon
gamma
il
interleukin
new
variant
influenza
viru
tnf
tumor
necrosi
factor
author
declar
compet
interest
